Project: nciOncology
Class Topoisomerase-II_Inhibitor

Concrete Class Extends 

        Topoisomerase_Inhibitor

 

Direct Instances:

None

 

Direct Subclasses:

1. Anthracycline_Antibiotic
2. Epipodophyllotoxin_Compound
3. Anthraquinone_Compound
4. Ciprofloxacin
5. Acridine_Carboxamide
6. Amonafide
7. Anthrapyrazole_Antibiotic
8. TAS-103
9. Fostriecin
10. Razoxane
11. XK469R
12. XK469
13. Chloroquinoxaline_Sulfonamide
14. Merbarone
15. Intoplicine
16. Elsamitrucin
17. CI-921
18. Pyrazoloacridine
19. Elliptinium
20. Amsacrine

Template Slots
Slot name	Documentation	Type	Allowed Values/Classes	Cardinality	Default
rChemical_or_Drug_Has_Biochemical_Class_or_Structure		Instance	Chemicals_and_Drugs_Kind	0:*
rChemical_or_Drug_Has_Target_Protein		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Target_Anatomy		Instance	Anatomy_Kind	0:*
rChemical_or_Drug_Affects_Cell_Type_or_Tissue		Instance	Anatomy_Kind	0:*
rChemical_or_Drug_Has_Source		Instance	Organism_Kind	0:*
rChemical_or_Drug_Has_Target_Organism		Instance	Organism_Kind	0:*
rChemical_or_Drug_Plays_Role_in_Biological_Process		Instance	Biological_Process_Kind	0:*
rChemical_or_Drug_Has_Biochemical_Function		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Receptor		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Associated_Pathology		Instance	Findings_and_Disorders_Kind	0:*
rChemical_or_Drug_FDA_Approved_for_Disease		Instance	Findings_and_Disorders_Kind	0:*
rChemical_or_Drug_is_Part_of_Chemical_or_Drug		Instance	Chemicals_and_Drugs_Kind	0:*

Own Slots
Slot name	Documentation	Type	Value	Cardinality
:OWL-DISJOINT-CLASSES		Instance

Return to class hierarchy